{
  "content": "5.\nHindricks, G. ∙ Potpara, T. ∙ Dagres, N. ∙ et al.\n2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the Europe\nEur Heart J. 2021; 42:373-498\nAvailable from: \nCrossref\nScopus (6515)\nPubMed\nGoogle Scholar\nIn acute-onset AF without haemodynamic compromise, some favour cardioversion—either electrical or pharmacological—whilst others favour rate control. Acute rate control has a rapid onset of action, dose-dependent effects, and is generally safe.7–11\n7.\nScheuermeyer, F.X. ∙ Grafstein, E. ∙ Stenstrom, R. ∙ et al.",
  "source": "https://www.thelancet.com/journals/lanepe/article/PIIS2666-7762(23)00220-X/fulltext",
  "chunk_id": "473005e1-e1a4-4702-a1e6-60dbbcbd1da7",
  "similarity_score": 0.3566475510597229,
  "query": "atrial fibrillation guidelines ESC AHA CCS amiodarone beta-blockers recommendations clinical practice first-line therapy",
  "rank": 33,
  "title": "Atrial fibrillation: better symptom control with rate and rhythm management",
  "authors": "Dhiraj Gupta, Michiel Rienstra, Isabelle C. van Gelder, Laurent Fauchier",
  "year": "2024",
  "journal": "The Lancet Regional Health – Europe",
  "reference": "Gupta, D., Rienstra, M., van Gelder, I. C., & Fauchier, L. (2024). Atrial fibrillation: better symptom control with rate and rhythm management. The Lancet Regional Health – Europe, 37100801. https://doi.org/10.1016/j.lanepe.2023.100801",
  "doi": "10.1016/j.lanepe.2023.100801",
  "chunk_index": 27,
  "total_chunks": 154,
  "retrieved_at": "2025-07-24T21:58:06.270585"
}